Recovery of neuromuscular function after atracurium and pancuronium maintenance of pancuronium block
- PMID: 8111941
- DOI: 10.1007/BF03009658
Recovery of neuromuscular function after atracurium and pancuronium maintenance of pancuronium block
Abstract
The study was undertaken to determine whether a neuromuscular blockade induced with pancuronium but maintained with atracurium was associated with a shorter time to complete recovery after administration of neostigmine than if the blockade was maintained with pancuronium alone. Anaesthesia consisted of thiopentone, N2O/O2/enflurane and fentanyl, and the neuromuscular blockade, induced by pancuronium 0.1 mg.kg-1 was monitored by the force of contraction of adductor pollicis during major abdominal surgery lasting 2-5 hr. In 24 patients--Group 1--atracurium 0.07 mg.kg-1 was repeated when the first twitch of the train-of-four (TOF) returned to 25% of control (T1/TC 25). In 28 patients--Group 2--pancuronium 0.015 mg.kg-1 was given at similar recovery of T1/TC. At the end of surgery, neostigmine 0.07 mg.kg-1 and glycopyrolate 0.015 mg.kg-1 were given to reverse the residual neuromuscular blockade which was indicated by a T1/TC of less than 25% in all patients. The time from injection of the reversal drugs to a TOF ratio of 70% was similar in both groups (Group 1, 11.6 +/- 7.6 min; Group 2, 10.1 +/- 6 min; P = NS), but the recovery index was smaller in Group 2 (Group 1, 4 +/- 2.6 min; Group 2, 2.61 +/- 1.2 min; P < 0.05). Furthermore, there was no difference between groups in the duration of action of each redose. The study showed that when compared with pancuronium, equipotent doses of atracurium were not associated with (a) a shorter time to complete recovery from a neuromuscular blockade induced with pancuronium or (b) a shorter duration of action.
Similar articles
-
Potentiation of atracurium by pancuronium during propofol-fentanyl-N2O anesthesia.Acta Anaesthesiol Belg. 1996;47(4):187-93. Acta Anaesthesiol Belg. 1996. PMID: 9093646 Clinical Trial.
-
Neostigmine and edrophonium as antagonists of atracurium and pancuronium.Acta Anaesthesiol Scand. 1988 Aug;32(6):437-40. doi: 10.1111/j.1399-6576.1988.tb02762.x. Acta Anaesthesiol Scand. 1988. PMID: 2845694 Clinical Trial.
-
Is recovery of neuromuscular transmission complete after the use of neostigmine to antagonize block produced by rocuronium, vecuronium, atracurium and pancuronium?Br J Anaesth. 1996 Oct;77(4):496-9. doi: 10.1093/bja/77.4.496. Br J Anaesth. 1996. PMID: 8942335 Clinical Trial.
-
Clinical pharmacology of vecuronium and atracurium.Anesthesiology. 1984 Oct;61(4):444-53. doi: 10.1097/00000542-198410000-00014. Anesthesiology. 1984. PMID: 6148907 Review.
-
Clinical pharmacology of the neuromuscular blocking agents.DICP. 1991 Jan;25(1):54-64. doi: 10.1177/106002809102500111. DICP. 1991. PMID: 1672571 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous